Mangalam Worldwide Q2 FY27: consolidated PAT jumps 31% YoY on steel volume growth
PAT +30.9% YoY · revenue +13.7% · margins expanding
₹360.4 Cr
+13.7% YoY
₹13.82 Cr
+30.9% YoY
3.83%
₹0.47
Mangalam Worldwide's consolidated PAT for Q2 FY27 (quarter ended 30-Sep-2026) rose 30.9% YoY to ₹13.82 Cr on revenue from operations of ₹360.40 Cr, up 13.7% YoY — the strongest YoY print the company has on record in our data, with PBT up a sharper 71.3% YoY to ₹17.73 Cr. Sequentially, revenue grew 14.0% and PAT 14.9% over Q1 FY27 (₹316.22 Cr / ₹12.02 Cr), continuing the growth seen last quarter rather than a one-off spike. Standalone and consolidated results are virtually identical (PAT ₹13.83 Cr vs ₹13.82 Cr, <0.1% apart), confirming the MSPL subsidiary contributes negligible minority interest post near-full integration.
Q2 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
Net profit margin expanded to 3.83% from 3.33% YoY (and 3.80% in Q1), while the company's own standalone operating-margin ratio widened to 10.16% from 8.63% QoQ. On a self-computed consolidated EBITDA basis, operating margin improved to ~10.97% from ~6.57% a year ago — but a meaningful share of that swing is an inventory-accounting effect rather than pricing or cost efficiency: the finished-goods/WIP stock build added back ₹45.22 Cr to this quarter's P&L versus ₹12.16 Cr a year ago, a ₹33.1 Cr favourable swing that alone exceeds the entire ₹18.69 Cr rise in consolidated EBITDA. Strip that out and cost growth (driven by raw materials tracking volumes, plus finance costs nearly doubling YoY to ₹17.89 Cr on NCD-funded borrowing) would have outpaced revenue growth — i.e., underlying margin improvement is more modest than the headline ratios suggest. Debt-equity rose to 1.19x from 0.81x at FY26-end as long-term borrowings grew 80% in the half, funding a capex ramp (gross PP&E up to ₹104.90 Cr from ₹77.55 Cr at March-2026).
The stock went into the print at ₹40.5, down 1.3% over the past month of trading.
There is no analyst coverage or consensus estimate on record for this micro-cap (a web search for Q2 FY27 previews/estimates returned none), so vs-street is unknown; management has also issued no formal guidance in our records or in public filings, so vs-guidance cannot be assessed either — both gaps are typical for a company of this size rather than a disclosure lapse. Three corporate developments from the quarter tie into the print: NSE returned MWL's applications for the MSPL amalgamation scheme and its ₹55.2 Cr convertible-warrant preferential issue (17-Sep-2026), leaving both corporate actions pending refiling; the company incorporated a wholly owned subsidiary in Belgium (2-Oct-2026) and was approved as a vendor by ADNOC (7-Sep-2026), both consistent with the stated push toward exports/international markets that the ongoing capex and debt build appear to be funding. No management press release accompanied this filing.
W1
Whether the ₹45.22 Cr finished-goods inventory build converts to dispatched sales next quarter without a margin giveback — tests if the OPM gain (10.16% standalone) is more than an accounting timing effect
W2
Refiling status of the NSE-returned MSPL amalgamation scheme and the ₹55.2 Cr (44,00,000 warrants at ₹125.40) preferential warrant issue, both returned 17-Sep-2026
W3
Finance-cost trajectory (₹17.89 Cr this quarter, +92.9% YoY) against the debt-funded capex ramp (PP&E +35% in the half) as debt-equity rose to 1.19x
Unaudited, limited-review only; no exceptional items in either period; standalone and consolidated PAT differ by <0.1% (NCI immaterial); EPS restated for the 1:10 stock split effective 10-Jul-2026 (pre-split-comparable basic EPS ~₹4.70); all figures converted from ₹ Lakhs.
Informational and educational content only. Not investment advice.